Virtus ETF Advisers LLC Mirum Pharmaceuticals, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 12,344 shares of MIRM stock, worth $579,550. This represents 0.23% of its overall portfolio holdings.

Number of Shares

12,344

Previous 12,344 -0.0%

Holding current value

$579,550

Previous $422,000 13.98%

% of portfolio

0.23%

Previous 0.22%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.57 - $34.85 $31,324 - $46,315	1,329 Added 12.07%	12,344 $422,000
Q1 2024 May 15, 2024	BUY	$24.92 - $30.02 $39,498 - $47,581	1,585 Added 16.81%	11,015 $276,000
Q4 2023 Feb 15, 2024	SELL	$27.14 - $34.93 $35,526 - $45,723	-1,309 Reduced 12.19%	9,430 $278,000
Q3 2023 Nov 07, 2023	SELL	$24.63 - $32.85 $34,235 - $45,661	-1,390 Reduced 11.46%	10,739 $339,000
Q2 2023 Aug 14, 2023	SELL	$23.51 - $30.09 $116,609 - $149,246	-4,960 Reduced 29.02%	12,129 $313,000
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $5,737 - $7,205	299 Added 1.78%	17,089 $410,000
Q4 2022 Feb 14, 2023	BUY	$17.59 - $23.83 $78,662 - $106,567	4,472 Added 36.3%	16,790 $327,000
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $3,616 - $5,328	181 Added 1.49%	12,318 $259,000
Q2 2022 Aug 12, 2022	BUY	$18.42 - $27.5 $17,977 - $26,840	976 Added 8.74%	12,137 $236,000
Q1 2022 May 16, 2022	SELL	$15.5 - $23.93 $10,168 - $15,698	-656 Reduced 5.55%	11,161 $246,000
Q4 2021 Feb 14, 2022	SELL	$13.05 - $19.35 $2,179 - $3,231	-167 Reduced 1.39%	11,817 $188,000
Q3 2021 Nov 15, 2021	SELL	$13.95 - $20.18 $8,621 - $12,471	-618 Reduced 4.9%	11,984 $239,000
Q2 2021 Aug 10, 2021	BUY	$15.84 - $20.6 $1,378 - $1,792	87 Added 0.7%	12,602 $218,000
Q1 2021 May 17, 2021	BUY	$16.29 - $21.92 $3,632 - $4,888	223 Added 1.81%	12,515 $248,000
Q4 2020 Feb 12, 2021	SELL	$15.75 - $25.45 $81,364 - $131,474	-5,166 Reduced 29.59%	12,292 $215,000
Q3 2020 Nov 13, 2020	SELL	$18.4 - $26.59 $43,736 - $63,204	-2,377 Reduced 11.98%	17,458 $336,000
Q2 2020 Aug 05, 2020	BUY	$11.51 - $20.97 $228,300 - $415,939	19,835 New	19,835 $386,000

Others Institutions Holding MIRM

# of Institutions

192

Shares Held

54M

Call Options Held

177K

Put Options Held

167K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.73B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Mirum Pharmaceuticals, Inc. Transaction History